7-151235296-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_019015.3(CHPF2):c.512T>C(p.Phe171Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F171V) has been classified as Uncertain significance.
Frequency
Consequence
NM_019015.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000255 AC: 64AN: 251346Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135882
GnomAD4 exome AF: 0.000230 AC: 336AN: 1461660Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 186AN XY: 727144
GnomAD4 genome AF: 0.000210 AC: 32AN: 152152Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.512T>C (p.F171S) alteration is located in exon 2 (coding exon 2) of the CHPF2 gene. This alteration results from a T to C substitution at nucleotide position 512, causing the phenylalanine (F) at amino acid position 171 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at